These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11932913)

  • 21. [131I-MIBG-meta-iodobencylguanidine (131I-MIBG) in the study of neuroblastoma].
    Ferris J; Caballero O; Verdeguer A; Esquembre C; Castel V
    An Esp Pediatr; 1987 Mar; 26(3):164-70. PubMed ID: 3579055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
    Défachelles AS; Cougnenc O; Carpentier P
    Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine.
    Huibregtse KE; Vo KT; DuBois SG; Fetzko S; Neuhaus J; Batra V; Maris JM; Weiss B; Marachelian A; Yanik GA; Matthay KK
    Eur J Cancer; 2016 Oct; 66():144-52. PubMed ID: 27573428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated Internal and External Radiation Exposure of Caregivers of Patients With Pediatric Neuroblastoma Undergoing 131I Metaiodobenzylguanidine Therapy: A Prospective Pilot Study.
    Han S; Yoo SH; Koh KN; Lee JJ
    Clin Nucl Med; 2017 Apr; 42(4):271-274. PubMed ID: 28098666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
    Matthay KK; Panina C; Huberty J; Price D; Glidden DV; Tang HR; Hawkins RA; Veatch J; Hasegawa B
    J Nucl Med; 2001 Nov; 42(11):1713-21. PubMed ID: 11696644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
    Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
    Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
    J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).
    Zhou MJ; Doral MY; DuBois SG; Villablanca JG; Yanik GA; Matthay KK
    Eur J Cancer; 2015 Nov; 51(16):2465-72. PubMed ID: 26254811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
    Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
    Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of an investigational radiopharmaceutical in neuroblastoma: a nursing perspective.
    Kelly JU
    J Pediatr Oncol Nurs; 1989 Oct; 6(4):133-8. PubMed ID: 2604936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
    Hammami H; Hassine L; Mhiri A; Sellem A; Oubich F; Gharssallah L; Barsaoui S; Ben Brahim H
    Tunis Med; 2007 May; 85(5):413-6. PubMed ID: 17657930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of thyroid blockade on thyroid radioiodine uptake in 123I-mIBG imaging.
    Friedman NC; Hassan A; Grady E; Matsuoka DT; Jacobson AF
    J Nucl Med; 2014 Feb; 55(2):211-5. PubMed ID: 24385600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
    Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of iodine-123 metaiodobenzylguanidine in childhood neuroblastoma: lack of relation to tumour differentiation in vivo.
    Brans B; Laureys G; Schelfhout V; Wiele CV; Potter CR; Dhooge C; Simons M; Dierckx RA
    Eur J Nucl Med; 1998 Feb; 25(2):144-9. PubMed ID: 9473262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
    J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonographic abnormalities of the thyroid gland following radiotherapy in survivors of childhood Hodgkin's disease.
    Healy JC; Shafford EA; Reznek RH; Webb JA; Thomas JM; Bomanji JB; Kingston JE
    Br J Radiol; 1996 Jul; 69(823):617-23. PubMed ID: 8696697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
    Schmidt M; Simon T; Hero B; Schicha H; Berthold F
    Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.